Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
O3R-5671 Pharmacokinetic and Pharmacodynamic Data to be Presented at ECCO and Dosing in Final Cohort in First-in-human study initiated
GlobeNewswire, Inc.
Data from the first in human study on O3R-5671’s potent TNFα inhibition to be presented Dosing of the final cohort in the first in human study has been initiated Studies in ulcerative colitis and psoriasis to initiate in H2 2026 Leuven, Belgium....
Waffle Maker Market Size to Reach US$414.0 Million by 2033 as Home Cooking Trends Drive Demand
EIN Presswire
North America leads the global waffle maker market with 42% revenue share in 2025, driven by U.S. breakfast culture, brunch demand, and gifting trends.
Title21 Health Solutions Acquires MyCellHub to Expand Digital Capabilities in Life Sciences and Advanced Therapies
EIN Presswire
Strategic acquisition accelerates Title21’s mission to deliver integrated digital solutions for regulated healthcare and life sciences in cell and gene therapy.
Agomab Announces Positive Phase 1 Interim Results with AGMB-447 in Healthy Participants and Initiation of Idiopathic Pulmonary Fibrosis Cohort
GlobeNewswire, Inc.
-- Interim data from Phase 1 with single and multiple ascending doses show no safety signals and a generally favorable tolerability profile of AGMB-447 in healthy participants -- -- Pharmacokinetic profile in healthy participants shows low...
Allegro to start production of osteoarthritis hydrogel as it prepares for clinical trials
GlobeNewswire, Inc.
Wallonia Minister of Economy and Employment Pierre-Yves Jeholet will perform opening ceremony on 9 January 2026 New cleanroom facility allows production of one million doses per year Ramping up for clinical development in osteoarthritis in 2026...
New site in Lommel, Belgium: Aqua free successfully completes set-up phase with ISO 9001 certification
GlobeNewswire, Inc.
Lommel / Hamburg, 01/15/2026 – Aqua free, a leading provider of innovative drinking-water hygiene solutions, has successfully moved into its new, state-of-the-art facility in Lommel and has now also obtained ISO 9001 certification for the site....
Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference
GlobeNewswire, Inc.
MELBOURNE, Australia and INDIANAPOLIS, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today advises that Dr. Christian Behrenbruch, Managing Director and Group CEO, will be presenting at the 44th...
Why Respiratory Vaccines Remain a Strategic Focus for Healthcare Systems Worldwide?
GlobeNewswire, Inc.
Ottawa, Jan. 05, 2026 (GLOBE NEWSWIRE) -- What are the Emerging Developments in the Respiratory Disease Vaccine?
Hemodialysis Chairs Market Outlook Highlights Strategic Opportunities Across The Industry
EIN Presswire
The Business Research Company's Hemodialysis Chairs Market Outlook Highlights Strategic Opportunities Across The Industry LONDON, GREATER LONDON, UNITED KINGDOM, August 10, 2026 /EINPresswire.com/ -- "The hemodialysis chairs market has been...
Belgium, Luxembourg, Malta Recognize State of Palestine
MENAFN
(MENAFN) In a significant diplomatic shift, Belgium, Luxembourg, and Malta have officially recognized Palestine as a state during a summit held alongside the United Nations General Assembly in New York, further bolstering European Union support...
Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire, Inc.
Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference Mont-Saint-Guibert, Belgium – December 29, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company...
Belgium Voices Unwavering Support for EU Sanctions on Israel
MENAFN
(MENAFN) Belgian Prime Minister Bart De Wever announced his country’s unwavering support for any European Union sanctions against Israel, following the escalating conflict in Gaza. De Wever argued that these measures are crucial to exert pressure...
Sequana Medical announces execution of letter of intent to amend terms of the Kreos Loan
GlobeNewswire, Inc.
Ghent, Belgium, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Sequana Medical announces execution of letter of intent to amend terms of the Kreos Loan PRESS RELEASE REGULATED INFORMATION / INSIDE INFORMATION 23 December 2025, 6:30 pm CET / 12:30 pm ET Letter...
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions
GlobeNewswire, Inc.
MELBOURNE, Australia and INDIANAPOLIS, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today provides a precision medicine portfolio update in relation to: TLX591-CDx (Illuccix® in approved...
Medical Health Screening Market to Reach USD $25.36 Billion by 2029 at 6.4% CAGR
EIN Presswire
The Business Research Company’s Medical Health Screening Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 22, 2025 /EINPresswire.com/ -- Get 30% Off All Global Market...
Generic Pharmaceuticals Contract Manufacturing Market to Reach USD 143.22 Billion by 2035, Driven by Demand for Affordable Therapies
GlobeNewswire, Inc.
Ottawa, Dec. 19, 2025 (GLOBE NEWSWIRE) -- The global generic pharmaceuticals contract manufacturing market size is calculated at USD 85.99 billion in 2026 and is expected to reach around USD 143.22 billion by 2035, growing at a CAGR of 5.85% for...
DP World Expands Cold Chain Capabilities With New €48M Antwerp Hub
GlobeNewswire, Inc.
ANTWERP, Belgium, Aug. 05, 2026 (GLOBE NEWSWIRE) -- DP World will build a new temperature-controlled logistics hub in the Port of Antwerp.
Sequana Medical Announces Granting of Key Additional U.S. Patent for DSR
GlobeNewswire, Inc.
Ghent, Belgium, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Builds upon existing granted DSR patents in US, Europe, Japan and China Strengthens DSR patent protection based upon extensive clinical and pre-clinical experience Data published in European...
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline
GlobeNewswire, Inc.
Transaction builds on argenx’s prior strategic investment in Forte Biosciences and reflects a disciplined approach to accessing novel biology that can fuel long-term growth FB102 Phase 1b studies in vitiligo and celiac disease validate CD122...
Pharmaceutical Contract Development & Manufacturing Organization (CDMO) For Formulations Market Grow at 10.7% CAGR 2029
EIN Presswire
The Business Research Company's Pharmaceutical CDMO For Formulations Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 23, 2025 /EINPresswire.com/ -- Get 30% Off All...
Sign up for:
Belgium Health Review
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.